Tom Angell Says "DEA Says It Is in the Process of Preparing Public Access to the Cannabis Rescheduling Proceedings Docket. For Now, Read Marijuana Moment's Coverage of the Latest Significant Filings:", 'DEA And Anti-Marijuana Group Deny Allegations...
Express News | IGC Pharma Inc - No Serious Adverse Events or Deaths Reported in Trial
IGC Pharma Announces Additional Phase 2 Interim Results Highlighting Cognitive Benefits of IGC-AD1 for Alzheimer's Treatment
India Globalization Capital GAAP EPS of -$0.02 Beats by $0.01, Revenue of $0.41M Beats by $0.21M
Express News | IGC Pharma Inc: Qtrly Loss per Share $0.02
Express News | IGC Pharma Q2 Operating Income USD -1.76 Million